Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06606509
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus T1DM
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Chinese Clinical Research Plan for the Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus T1DM
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multicenter cross-sectional research project planning to enroll 1000 patients with Type 1 Diabetes Mellitus T1DM By reviewing clinical data physical examinations questionnaires continuous glucose monitoring and subcutaneous fat ultrasound we aim to understand the current status of treatment and metabolism in Chinese T1DM patients and analyze the potential factors that may affect their blood sugar control and metabolic indicators A cost-effectiveness analysis will be conducted on Chinese T1DM patients using continuous glucose monitoring systems to identify the groups that benefit most from these systems
Detailed Description:
This study is a multicenter cross-sectional research project planning to enroll 1000 patients with Type 1 Diabetes Mellitus T1DM This study will collect multicenter data on T1DM patients including sociodemographic information anthropometric measurements glycemic indices glycated hemoglobin fasting blood glucose postprandial blood glucose acute and chronic complications other important metabolic indicators blood lipids vitamin D insulin treatment methods blood glucose monitoring status diabetes education diet and exercise social and psychological support and extra-pancreatic autoimmune diseases The aims are 1 To understand the current state of treatment and glycemic metabolism in Chinese T1DM patients and to analyze the potential factors that may affect their glycemic indices 2 To understand the current status of continuous glucose monitoring CGM usage in Chinese T1DM patients and to analyze the impact of CGM on blood glucose control acute and chronic complications and quality of life in T1DM patients 3 Through cost-benefit analysis to identify potential beneficiary groups for CGM providing objective evidence for the demand of this technology to healthcare professionals and diabetes patients to provide effective information for the formulation of medical insurance reimbursement policies for continuous glucose monitoring
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None